Craig Stephens
YOU?
Author Swipe
View article: Genome sequence of <i>Streptomyces</i> sp. DSM 42143
Genome sequence of <i>Streptomyces</i> sp. DSM 42143 Open
We report the 7.9 Mb genome sequence of Streptomyces sp. DSM 42143, which contains a 7,807,748 bp linear chromosome and a 108,164 bp circular plasmid. AntiSMASH predicted 39 diverse biosynthetic gene clusters, suggesting that this strain m…
View article: Genome sequence of <i>Streptomyces auratus</i> DSM 41897
Genome sequence of <i>Streptomyces auratus</i> DSM 41897 Open
We report the genomic DNA sequence of the actinomycete Streptomyces auratus DSM 41897. The genome assembled as two linear chromosomal contigs (4,434,406 bp and 3,992,024 bp) and a circular plasmid (12,008 bp), with an overall GC content of…
View article: The Scr and Csc pathways for sucrose utilization co-exist in E. coli, but only the Scr pathway is widespread in other Enterobacteriaceae
The Scr and Csc pathways for sucrose utilization co-exist in E. coli, but only the Scr pathway is widespread in other Enterobacteriaceae Open
Most Escherichia coli isolates from humans do not utilize D-sucrose as a substrate for fermentation or growth. Previous work has shown that the Csc pathway allows some E. coli to utilize sucrose for slow growth, and this pathway has been e…
View article: Genome sequences of key bacterial symbionts of entomopathogenic nematodes: <i>Xenorhabdus cabanillasii</i> DSM17905, <i>Xenorhabdus ehlersii</i> DSM16337, <i>Xenorhabdus japonica</i> DSM16522, <i>Xenorhabdus koppenhoeferii</i> DSM18168, and <i>Xenorhabdus mauleonii</i> DSM17908
Genome sequences of key bacterial symbionts of entomopathogenic nematodes: <i>Xenorhabdus cabanillasii</i> DSM17905, <i>Xenorhabdus ehlersii</i> DSM16337, <i>Xenorhabdus japonica</i> DSM16522, <i>Xenorhabdus koppenhoeferii</i> DSM18168, and <i>Xenorhabdus mauleonii</i> DSM17908 Open
Xenorhabdus species are bacterial symbionts of entomopathogenic Steinernema nematodes, in which they produce diverse secondary metabolites implicated in pathogenesis. To expand resources for natural product prospecting and exploration of h…
View article: Supplementary Figure S1 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S1 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFB mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Supplementary Figure S8 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S8 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFB mRNA levels in CLM for OS (complete response, CR; standard error, SE)
View article: Supplementary Figure S4 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S4 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for KDR mRNA levels in CLM for RFS (complete response, CR)
View article: Supplementary Figure S6 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S6 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for EPHB4 mRNA levels in CLM for RFS (complete response, CR)
View article: Supplementary Figure S7 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S7 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for ACVRL1 mRNA levels in CLM for OS (complete response, CR; standard error, SE)
View article: Table S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Table S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Patients' characteristics of JACCRO CC-05/06 and 05/06AR trials
View article: Supplementary Figure S3 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S3 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for HIF1A mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Supplementary Figure S5 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S5 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for EGFL7 mRNA levels in CLM for RFS (complete response, CR)
View article: Supplementary Figure S2 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S2 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFC mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Figure S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Figure S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Consort flow diagram of the study
View article: Supplementary Figure S1 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S1 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFB mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Supplementary Figure S3 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S3 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for HIF1A mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Data from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Data from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Angiogenesis-related gene expression is associated with the efficacy of anti-VEGF therapy. We tested whether intratumoral mRNA expression levels of genes involved in vascular morphogenesis and early vessel maturation predict response, recu…
View article: Data from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Data from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Angiogenesis-related gene expression is associated with the efficacy of anti-VEGF therapy. We tested whether intratumoral mRNA expression levels of genes involved in vascular morphogenesis and early vessel maturation predict response, recu…
View article: Supplementary Figure S7 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S7 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for ACVRL1 mRNA levels in CLM for OS (complete response, CR; standard error, SE)
View article: Supplementary Figure S5 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S5 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for EGFL7 mRNA levels in CLM for RFS (complete response, CR)
View article: Supplementary Figure S8 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S8 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFB mRNA levels in CLM for OS (complete response, CR; standard error, SE)
View article: Supplementary Figure S6 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S6 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for EPHB4 mRNA levels in CLM for RFS (complete response, CR)
View article: Supplementary Figure S4 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S4 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for KDR mRNA levels in CLM for RFS (complete response, CR)
View article: Figure S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Figure S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Consort flow diagram of the study
View article: Data from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Data from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Molecular differences in tumor locations may contribute to the sidedness-specific response to cetuximab in metastatic colorectal cancer (mCRC). We investigated genes associated with the response to cetuximab treatment depending on tumor si…
View article: Supplementary Figure S2 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection
Supplementary Figure S2 from Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection Open
Kaplan Meier curves for VEGFC mRNA levels in CLM for RFS (complete response, CR; not reached, NR)
View article: Table S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Table S1 from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Patients' characteristics of JACCRO CC-05/06 and 05/06AR trials
View article: Data from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer
Data from Tumor Sidedness and Enriched Gene Groups for Efficacy of First-line Cetuximab Treatment in Metastatic Colorectal Cancer Open
Molecular differences in tumor locations may contribute to the sidedness-specific response to cetuximab in metastatic colorectal cancer (mCRC). We investigated genes associated with the response to cetuximab treatment depending on tumor si…
View article: GAMBIT (Genomic Approximation Method for Bacterial Identification and Tracking): A methodology to rapidly leverage whole genome sequencing of bacterial isolates for clinical identification
GAMBIT (Genomic Approximation Method for Bacterial Identification and Tracking): A methodology to rapidly leverage whole genome sequencing of bacterial isolates for clinical identification Open
Whole genome sequencing (WGS) of clinical bacterial isolates has the potential to transform the fields of diagnostics and public health. To realize this potential, bioinformatic software that reports identification results needs to be deve…
View article: Is There a Universal Endurance Microbiota?
Is There a Universal Endurance Microbiota? Open
Billions of microbes sculpt the gut ecosystem, affecting physiology. Since endurance athletes’ performance is often physiology-limited, understanding the composition and interactions within athletes’ gut microbiota could improve performanc…